| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.5 |